51 studies found for:    NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
RSS Create an RSS feed from your search for:
NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
2 Recruiting Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Conditions: MUD Transplant;   AlloPBSC;   Congenital Immunodeficiencies;   HLA Matched Transplant;   BMT
Interventions: Drug: Busulfan;   Drug: Campath-1 H;   Drug: Sirolimus;   Procedure: BMT;   Procedure: Apheresis;   Procedure: Total Body Irradiation;   Procedure: GCSF Injections
3 Recruiting Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Conditions: Food Hypersensitivity;   Eosinophilia;   Peanut Hypersensitivity;   Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention:
4 Recruiting Screening Protocol for Genetic Diseases of Mast Cell Homeostasis and Activation
Conditions: Piebaldism;   Idiopathic Anaphylaxis;   Allergy;   Chronic Urticara;   Angioedema
Intervention:
5 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Conditions: Atopic Dermatitis;   Netheron's Syndrome;   Piebaldism;   Hyper IgE Syndrome;   Ichthyosis;   Anaphylaxis;   Severe Allergy
Intervention:
6 Recruiting Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics
Conditions: Chronic Disease;   Healthy;   Lyme Arthritis;   Lyme Disease;   Multiple Sclerosis
Intervention:
7 Recruiting Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Condition: Diabetes Mellitus, Type I
Interventions: Drug: Low Molecular Weight Sulfated Dextran (LMW-SD);   Drug: Heparin;   Drug: CellCept® (Mycophenolate mofetil) OR Rapamune® (Sirolimus);   Drug: Prograf® (Tacrolimus) OR Cyclosporine;   Drug: Thymoglobulin® (Anti-thymocyte Globulin) - at first transplant;   Drug: Simulect® (Basiliximab) - at 2nd or 3rd transplant;   Drug: Klexane® (Enoxaparinsodium);   Drug: Trombyl® or Albyl-E® (Acetylsalicylicacid- ASA);   Drug: Enbrel® (Etanercept)
8 Recruiting Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients
Condition: Kidney Transplantation
Intervention:
9 Recruiting Collection of Samples and Data for the National Marrow Donor Program Repository
Condition: Hematopoietic Stem Cell Transplantation
Intervention:
10 Recruiting Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
Condition: Inflammatory Disorder
Intervention:
11 Recruiting Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Conditions: Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention: Drug: sirolimus
12 Recruiting Efficacy of Islet After Kidney Transplantation
Condition: Type 1 Diabetes Mellitus
Intervention: Biological: Islet transplant
13 Recruiting Asthma Phenotypes in the Inner City
Condition: Asthma
Intervention: Drug: Flovent Diskus, Advair Diskus, Ventolin HFA, cetirizine, Flonase Nasal Spray, Singulair
14 Recruiting A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: abatacept;   Drug: Placebo
15 Recruiting Comparison of Airway Remodeling Mediators Following Experimental Human Rhinovirus Infection in Subjects With Mild to Moderate Asthma and in Healthy, Non-asthmatic Control Subjects.
Condition: Asthma
Intervention: Biological: GMP-grade HRV-39
16 Recruiting Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
Condition: Asthma
Interventions: Biological: Omalizumab;   Drug: Fluticasone;   Biological: Placebo omalizumab;   Biological: Placebo fluticasone
17 Recruiting Viral Triggers in Pediatric Lung Transplantation
Conditions: Lung Transplant;   Bronchiolitis Obliterans;   Obliterative Bronchiolitis
Intervention:
18 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
19 Recruiting Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Condition: Kidney Transplant
Interventions: Drug: Tacrolimus + MMF + Prednisone, followed by Tacrolimus Withdrawal;   Drug: MMF/Tacrolimus/Prednisone
20 Recruiting Optimization of NULOJIX® (Belatacept) Usage as a Means of Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Condition: Pancreas and Kidney Transplant
Interventions: Biological: Belatacept;   Drug: Medrol;   Biological: Anti-thymocyte Globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years